Ascendis Pharma A/S Current Financial Liabilities
Ascendis Pharma A/S (ASND) had Current Financial Liabilities of EUR 834.47 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:CurrentFinancialLiabilities · last filed 2026-02-11
- 2025-12-31: Current Financial Liabilities 834.47M EUR.
- 2025-09-30: Current Financial Liabilities 795.69M EUR.
- 2025-06-30: Current Financial Liabilities 746.22M EUR.
- 2025-03-31: Current Financial Liabilities 752.78M EUR.
| Period end | Current Financial Liabilities | Current Financial Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 834.47M EUR 20-F · filed 2026-02-11 | |
| 2025-09-30 | 795.69M EUR 6-K · filed 2025-11-12 | |
| 2025-06-30 | 746.22M EUR 6-K · filed 2025-08-07 | |
| 2025-03-31 | 752.78M EUR 6-K · filed 2025-05-01 | |
| 2024-12-31 | 738.91M EUR 20-F · filed 2026-02-11 | |
| 2024-09-30 | 693.63M EUR 6-K · filed 2024-11-14 | |
| 2024-06-30 | 712.48M EUR 6-K · filed 2024-09-03 | |
| 2024-03-31 | 731.50M EUR 6-K · filed 2024-05-02 | |
| 2023-12-31 | 659.13M EUR 20-F · filed 2025-02-12 | 119.97M EUR 20-F · filed 2024-02-07 |
| 2023-03-31 | 156.83M EUR 6-K · filed 2023-04-27 | |
| 2022-12-31 | 126.45M EUR 20-F · filed 2024-02-07 | |
| 2022-09-30 | 106.20M EUR 6-K · filed 2022-11-02 | |
| 2022-06-30 | 89.06M EUR 6-K · filed 2022-08-10 | |
| 2022-03-31 | 79.61M EUR 6-K · filed 2022-05-11 | |
| 2021-12-31 | 66.41M EUR 20-F · filed 2023-02-16 |